The young population faces an increasing health challenge posed by brain tumors affecting adolescents and children. While their occurrence isn’t as common…
Immunotherapy, an approach that seeks to stimulate the immune system to attack and destroy cancer cells, is a new field of research…
OTLC’s Deciparticle(TM) platform reliably formulates diverse hydrophobic drugs—including macrolide mTOR inhibitors, peptides, and polyketides—into uniform, IV-ready nanoparticles. Current Preclinical PK…
Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events identified during the treatment period.…
A recent report from India is a stark reminder of ricin’s accessibility and the pressing need for effective countermeasures. Ricin…
The U.S. House of Representatives passed a healthcare bill that didn’t include an extension of the ACA tax credits that…
In the U.S. about 15 million individuals live with long Covid, according to Department of Health & Human Services. For a long time, the scientific community…
Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has advanced nanoparticle-based delivery strategies through…
A new study done in India has produced results that bring into question the longstanding assumption that treating cancer requires tumors to…
Industry data shows small molecules achieve 5–10% approval rates over 15–20 years; antisense oligonucleotides (“ASOs”) are shifting the odds through…